Yan-Qiong Zhang (Yanqiong Zhang)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Neuropathic Pain

Radical Prostatectomy

Mesenchymal Stem Cells

Top Venues

Clinical and translational medicine

Signal transduction and targeted therapy

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Xia Mao, Kexin Wang, Yudong Liu, Xiaohui Su, Anguo Wu, Lin Chen, Jiangrui Wang, Beilei Cai, Yan-Qiong Zhang, Feng Huang, Na Lin
Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy. Clinical and translational medicine 13 (3) (2023)
Xia Mao, Kexin Wang, Yudong Liu, Xiaohui Su, Anguo Wu, Lin Chen, Jiangrui Wang, Beilei Cai, Yan-Qiong Zhang, Feng Huang, Na Lin
Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy. Clinical and translational medicine 13 (3) (2023)
Yudong Liu, Jia Xu, Zecong Yu, Tong Chen, Ning Wang, Xia Du, Ping Wang, Xuezhong Zhou, Haiyu Xu, Yan-Qiong Zhang
Ontology characterization, enrichment analysis, and similarity calculation-based evaluation of disease-syndrome-formula associations by applying SoFDA. iMeta 2 (2) (2023)
Yan Jia, Yan-Qiong Zhang, Shuwen Li, Ruihan Li, Weijie Li, Taixian Li, Rongtian Wang, Guangrui Huang, Haijun He, Na Lin, Weiheng Chen
Identification and assessment of novel dynamic biomarkers for monitoring non-traumatic osteonecrosis of the femoral head staging. Clinical and translational medicine 13 (6) (2023)
Yudong Liu, Jia Xu, Zecong Yu, Tong Chen, Ning Wang, Xia Du, Ping Wang, Xuezhong Zhou, Haiyu Xu, Yan-Qiong Zhang
Ontology characterization, enrichment analysis, and similarity calculation-based evaluation of disease-syndrome-formula associations by applying SoFDA. iMeta 2 (2) (2023)
Jianheng Ye, Shanghua Cai, Yuanfa Feng, Jinchuang Li, Zhiduan Cai, Yulin Deng, Ren Liu, Xuejin Zhu, Jianming Lu, Yangjia Zhuo, Yingke Liang, Jianjiang Xie, Yan-Qiong Zhang, Huichan He, Zhaodong Han, Zhenyu Jia, Weide Zhong
Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal transduction and targeted therapy 8 (1) (2023)
Xia Mao, Kexin Wang, Yudong Liu, Xiaohui Su, Anguo Wu, Lin Chen, Jiangrui Wang, Beilei Cai, Yan-Qiong Zhang, Feng Huang, Na Lin
Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy. Clinical and translational medicine 13 (3) (2023)
Yu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, Yang-Jia Zhuo, Jian-Heng Ye, Xue-Jin Zhu, Zhou-Da Cai, Zhuo-Yuan Lin, Ru-Jun Mo, Shu-Lin Wu, Yan-Qiong Zhang, Wei-De Zhong
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer. Disease markers 2022 (2022)
Wenjia Chen, Zhaochen Ma, Lingxiang Yu, Xia Mao, Nan Ma, Xiaodong Guo, Xiaoli Yin, Funeng Jiang, Qian Wang, Jigang Wang, Mingliang Fang, Na Lin, Yan-Qiong Zhang
Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation. Experimental & molecular medicine 54 (9) (2022)
Qiuyan Guo, Weijie Li, Chao Wang, Xia Mao, Xiaoyue Wang, Wenjia Chen, Haiyu Xu, Qian Wang, Yan-Qiong Zhang, Na Lin
Biomolecular network-based synergistic drug combination discovery: a combination of paeoniflorin and liquiritin alleviates neuropathic pain by inhibiting neuroinflammation via suppressing the chemokine signaling pathway. Signal transduction and targeted therapy 5 (1) (2020)
Ya Lin, Yan-Qiong Zhang, Erxin Shang, Wenfang Lai, Hongwei Zhu, Yuhua Fang, Qingxia Qin, Haiyu Zhao, Na Lin
Corrigendum to "Effect of Glycyrrhiza on the Diuretic Function of Euphorbia kansui: An Ascites Mouse Model". Evidence-based complementary and alternative medicine : eCAM 2018 (2018)